
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Janux Therapeutics Inc is an innovative biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to better treat patients suffering from cancer. Janux Therapeutics Inc is an innovative biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to better treat patients suffering from cancer.
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -1.82 | -5.85774058577 | 31.07 | 31.63 | 29.25 | 1150656 | 30.62265364 | CS |
4 | -7.79 | -21.0313174946 | 37.04 | 38.42 | 29.25 | 929933 | 33.3847633 | CS |
12 | -31.58 | -51.9151734342 | 60.83 | 62.3 | 29.25 | 956021 | 42.80747049 | CS |
26 | -15.47 | -34.5930232558 | 44.72 | 71.71 | 29.25 | 944661 | 49.07880561 | CS |
52 | -12.73 | -30.3239637923 | 41.98 | 71.71 | 29.25 | 818509 | 47.61440121 | CS |
156 | 11.52 | 64.9746192893 | 17.73 | 71.71 | 5.65 | 379868 | 41.53183443 | CS |
260 | -4.75 | -13.9705882353 | 34 | 71.71 | 5.65 | 336233 | 39.84377259 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions